Reckitt Benckiser Group plc (OTCMKTS:RBGLY) Declares Dividend of $0.29

Reckitt Benckiser Group plc (OTCMKTS:RBGLY) announced a dividend on Saturday, March 15th, NASDAQ Dividends reports. Stockholders of record on Friday, April 11th will be given a dividend of 0.2909 per share on Thursday, June 5th. The ex-dividend date is Friday, April 11th. This is a 51.9% increase from Reckitt Benckiser Group’s previous dividend of $0.19.

Reckitt Benckiser Group Price Performance

OTCMKTS RBGLY opened at $13.33 on Friday. Reckitt Benckiser Group has a one year low of $10.24 and a one year high of $14.10. The stock’s 50 day simple moving average is $12.98 and its 200 day simple moving average is $12.48. The company has a debt-to-equity ratio of 0.97, a quick ratio of 0.47 and a current ratio of 0.69.

Wall Street Analysts Forecast Growth

A number of research firms recently commented on RBGLY. Hsbc Global Res upgraded Reckitt Benckiser Group from a “hold” rating to a “strong-buy” rating in a research report on Wednesday, December 11th. Royal Bank of Canada restated an “outperform” rating on shares of Reckitt Benckiser Group in a research report on Friday, March 7th. Barclays lowered Reckitt Benckiser Group from an “overweight” rating to an “equal weight” rating in a research report on Tuesday, February 4th. Finally, HSBC upgraded Reckitt Benckiser Group from a “hold” rating to a “buy” rating in a research report on Wednesday, December 11th. Three analysts have rated the stock with a hold rating, two have given a buy rating and three have given a strong buy rating to the stock. Based on data from MarketBeat, Reckitt Benckiser Group has an average rating of “Buy”.

About Reckitt Benckiser Group

Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products worldwide. It offers acne treatment creams, facial washes, and cleansing pads; germ protection products; condoms; heartburn and indigestion solutions; joints health products; chest congestion, cough, and sinus remedies; brain health products; migraine-headaches and rheumatic pain products; sore throat medications; and hair removal products under the Airborne, Clearasil, Dettol, Durex, Gaviscon, Move Free, Neuriva, Nurofen, Mucinex, Strepsils, and Veet brands.